Navega Therapeutics
Harnessing the precision of zinc-finger and CRISPR based epigenome regulation to enable next-generation gene therapies.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredMar 10, 2018 (8 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
AM
Ana Moreno FounderFA
Fernando Aleman FounderPM
Prashant Mali Founder- CGCarol Greve-Philips CBO
Investors
CCalifornia Institute for Regenerative Medicine
CCreative Destruction Lab
NNational Cancer Institute
NNational Institute of Neurological Disorders and Stroke
Companies like Navega Therapeutics
NNeurosterix$105M Series B+ · Nov 2026
KKate Therapeutics$51M Series A · Jun 2023
EEvolyra TherapeuticsSeed · Apr 2026
CCoultreon$125M Series A · Apr 2026SSynthego$200M Series B+ · Feb 2022
AAmino Labs
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/navega-therapeutics (get a free API key).